We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for November 27th
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 27th:
Care.com, Inc. : This provider of online marketplace for finding and managing family care has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 29.3% over the last 60 days.
Vector Group Ltd. (VGR - Free Report) : This manufacturer and seller of cigarettes has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
TriNet Group, Inc. (TNET - Free Report) : This human resources solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 33.6% over the last 60 days.
Collegium Pharmaceutical, Inc. (COLL - Free Report) : This developer of abuse-deterrent products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.7% over the last 60 days.
Collegium Pharmaceutical, Inc. Price and Consensus
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for November 27th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 27th:
Care.com, Inc. : This provider of online marketplace for finding and managing family care has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 29.3% over the last 60 days.
Care.com, Inc. Price and Consensus
Care.com, Inc. Price and Consensus | Care.com, Inc. Quote
Care.com’s shares gained 21.9% over the last one month more than S&P 500’s gain of 1.6%. The company possesses a Momentum Score of B.
Care.com, Inc. Price
Care.com, Inc. price | Care.com, Inc. Quote
Vector Group Ltd. (VGR - Free Report) : This manufacturer and seller of cigarettes has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
Vector Group Ltd. Price and Consensus
Vector Group Ltd. Price and Consensus | Vector Group Ltd. Quote
Vector Group’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of B.
Vector Group Ltd. Price
Vector Group Ltd. price | Vector Group Ltd. Quote
TriNet Group, Inc. (TNET - Free Report) : This human resources solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 33.6% over the last 60 days.
TriNet Group, Inc. Price and Consensus
TriNet Group, Inc. Price and Consensus | TriNet Group, Inc. Quote
TriNet Group’s shares gained 27.4% over the last one month. The company possesses a Momentum Score of B.
TriNet Group, Inc. Price
TriNet Group, Inc. price | TriNet Group, Inc. Quote
Collegium Pharmaceutical, Inc. (COLL - Free Report) : This developer of abuse-deterrent products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.7% over the last 60 days.
Collegium Pharmaceutical, Inc. Price and Consensus
Collegium Pharmaceutical, Inc. Price and Consensus | Collegium Pharmaceutical, Inc. Quote
Collegium Pharmaceutical’s shares gained 64.5% over the last one month. The company possesses a Momentum Score of A.
Collegium Pharmaceutical, Inc. Price
Collegium Pharmaceutical, Inc. price | Collegium Pharmaceutical, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>